Published in JAMA on May 19, 2010
Subjective wellbeing, health, and ageing. Lancet (2014) 1.77
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int (2011) 1.31
Association between inflammatory-related disease burden and frailty: results from the Women's Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr (2011) 1.31
Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol (2011) 1.24
Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol (2011) 1.19
The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep (2012) 1.06
Associations between depressive symptoms and incident ESRD in a diabetic cohort. Clin J Am Soc Nephrol (2014) 0.94
Black-White differences in the effect of baseline depressive symptoms on deaths due to renal diseases: 25 year follow up of a nationally representative community sample. J Renal Inj Prev (2015) 0.92
Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int (2011) 0.88
Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation (2011) 0.88
Diabetes self-care, major depression, and chronic kidney disease in an outpatient diabetic population. Nephron Clin Pract (2013) 0.86
Depressed mood, usual activity level, and continued employment after starting dialysis. Clin J Am Soc Nephrol (2010) 0.85
Religiously integrated cognitive behavioral therapy: a new method of treatment for major depression in patients with chronic medical illness. Psychotherapy (Chic) (2014) 0.84
Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study. BMC Nephrol (2013) 0.83
Depression and its associated factors in pediatric chronic kidney disease. Pediatr Nephrol (2013) 0.83
Prevalence and correlates of depression among chronic kidney disease patients in Taiwan. BMC Nephrol (2013) 0.83
Association of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD. Clin J Am Soc Nephrol (2012) 0.83
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials (2012) 0.81
Chronic kidney disease care in the US safety net. Adv Chronic Kidney Dis (2015) 0.81
Patient's perceptions of chronic kidney disease and their association with psychosocial and clinical outcomes: a narrative review. Clin Kidney J (2016) 0.81
Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies. Am J Kidney Dis (2012) 0.80
Association between estimated GFR, health-related quality of life, and depression among older adults with diabetes: the Diabetes and Aging Study. Am J Kidney Dis (2013) 0.80
Chronic kidney disease: Depression is associated with poor outcomes in early CKD. Nat Rev Nephrol (2010) 0.80
Depressive Symptoms in Children with Chronic Kidney Disease. J Pediatr (2015) 0.80
Depression as a non-causal variable risk marker in coronary heart disease. BMC Med (2013) 0.78
The Combined Influence of Psychological Factors on Biomarkers of Renal Functioning in African Americans. Ethn Dis (2015) 0.77
Is inflammation a new risk factor of depression in haemodialysis patients? Int Urol Nephrol (2012) 0.77
Prediction of treatment outcomes in psychiatry--where do we stand ? Dialogues Clin Neurosci (2014) 0.76
Consequences of CKD on Functioning. Semin Nephrol (2016) 0.75
Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study. BMC Nephrol (2015) 0.75
Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes. Am J Nephrol (2016) 0.75
A Patient-Held Medical Record Integrating Depression Care into Diabetes Care. Jpn Clin Med (2016) 0.75
Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women's Medical University (DIACET). BMJ Open Diabetes Res Care (2016) 0.75
Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS One (2017) 0.75
Impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression: protocol for a cohort study. BMC Fam Pract (2015) 0.75
Effects of acceptance of disability on death or dialysis in chronic kidney disease patients: a 3-year prospective cohort study. BMC Nephrol (2015) 0.75
Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis. Front Psychol (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Deaths: final data for 2006. Natl Vital Stat Rep (2009) 6.89
Examining a bidirectional association between depressive symptoms and diabetes. JAMA (2008) 6.83
Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol (1998) 4.67
Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation (2002) 3.47
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int (2008) 3.34
Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med (2000) 2.86
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation (2000) 2.71
Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int (2000) 2.51
Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int (1998) 2.26
Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int (2002) 2.24
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol (2006) 2.23
Prevalence of major depressive episode in CKD. Am J Kidney Dis (2009) 1.79
Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis (2005) 1.78
Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol (1996) 1.76
The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int (2006) 1.73
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52
Validation of depression screening scales in patients with CKD. Am J Kidney Dis (2009) 1.43
Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil (2003) 1.41
Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry (2006) 1.37
Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial (2005) 1.34
Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. Am J Kidney Dis (2005) 1.27
Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis (2009) 1.21
Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol (2003) 1.19
Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis (2003) 1.17
Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis (1990) 1.12
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis (2003) 1.12
Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis (2003) 1.09
Predictors of survival among hemodialysis patients: effect of perceived family support. Health Psychol (1994) 1.04
Psychosocial and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom (1996) 1.01
The relation of stress and depression to interdialytic weight gain in hemodialysis patients. Behav Med (1995) 0.94
Serum albumin and depression in end-stage renal disease. Adv Perit Dial (1997) 0.91
Biopsychosocial aspects of long-term survival on end-stage renal failure therapy. Psychol Med (1989) 0.91
Influence of psychosocial factors on survival of home-dialysis patients. Lancet (1981) 0.90
The relationship of depression to survival in chronic renal failure. Psychosom Med (1986) 0.87
The effect of depressive symptoms on survival in peritoneal dialysis patients. Perit Dial Int (2004) 0.85
Non-compliance to diet and fluid restrictions in haemodialysis patients. J Pak Med Assoc (1995) 0.83
A cohort study to assess the impact of depression on patients with kidney disease. Int J Psychiatry Med (2006) 0.82
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry (2003) 13.60
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med (2011) 8.54
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension (2008) 6.96
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA (2006) 6.26
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med (2006) 6.00
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Medication augmentation after the failure of SSRIs for depression. N Engl J Med (2006) 5.16
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
Exercise treatment for depression: efficacy and dose response. Am J Prev Med (2005) 4.99
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol (2008) 3.65
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry (2008) 3.40
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol (2009) 3.30
Estimating Individualized Treatment Rules Using Outcome Weighted Learning. J Am Stat Assoc (2012) 3.13
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry (2006) 2.90
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry (2007) 2.87
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet (2006) 2.55
Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis (2012) 2.51
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry (2005) 2.50
STAR*D: what have we learned? Am J Psychiatry (2007) 2.47
Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry (2008) 2.42
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry (2006) 2.21
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry (2004) 2.11
The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep (2007) 2.08
Evidence-based recommendations for the prescription of exercise for major depressive disorder. J Psychiatr Pract (2013) 2.04
Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res (2013) 1.99
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry (2005) 1.99
Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders. Neuropsychopharmacology (2006) 1.93
Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry (2002) 1.93
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry (2008) 1.92
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry (2006) 1.90
Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract (2006) 1.89
Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am J Psychiatry (2007) 1.88
The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry (2008) 1.86
Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry (2010) 1.85
The pattern of sensory processing abnormalities in autism. Autism (2006) 1.83
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry (2010) 1.82
Gender differences in depression: findings from the STAR*D study. J Affect Disord (2005) 1.80
Prevalence of major depressive episode in CKD. Am J Kidney Dis (2009) 1.79
Effect of age at onset on the course of major depressive disorder. Am J Psychiatry (2007) 1.78
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.78
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv (2009) 1.77
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry (2005) 1.76
Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res (2005) 1.75
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry (2004) 1.75
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry (2003) 1.72
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry (2008) 1.70
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study. J Clin Psychiatry (2005) 1.70
Prospective trial of equine-assisted activities in autism spectrum disorder. Altern Ther Health Med (2011) 1.69
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis (2006) 1.68
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatr Scand (2009) 1.67
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc (2006) 1.66
Measurement-based care in psychiatric practice: a policy framework for implementation. J Clin Psychiatry (2011) 1.65
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med (2004) 1.64
Customizing treatment to the patient: adaptive treatment strategies. Drug Alcohol Depend (2007) 1.63
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry (2013) 1.61
Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry (2005) 1.61
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry (2005) 1.60
The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol (2006) 1.58
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry (2005) 1.57
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry (2008) 1.57